Cancer Research UK's Centre for Drug Development (CDD), in partnership with Amgen Inc., has launched a new clinical trial to test a drug that could stop a patient's immune system from protecting tumours.

Detecting molecular alterations in early breast cancer development is key in the development of more effective cancer prevention and early detection strategies. New research funded by The Eve Appeal and the European Union's ...

International liver cancer guidelines could be preventing patients from getting life-saving treatments in developing countries, according to a new study published in the journal Heliyon. The authors of the research are calling ...

A group of protein kinases have been found to play an important role in embryo development and may even be a potential cancer drug target, says research led by Queen Mary University of London (QMUL) and the Francis Crick ...

The high amounts of dietary sugar in the typical Western diet may increase the risk of breast cancer and metastasis to the lungs, according to a study at The University of Texas MD Anderson Cancer Center.